B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

DDR1

MOLECULAR TARGET

discoidin domain receptor tyrosine kinase 1

UniProt: Q08345NCBI Gene: 78068 compounds

DDR1 (discoidin domain receptor tyrosine kinase 1) is targeted by 68 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting DDR1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1erlotinib5.55256
2imatinib5.47236
3sb 2035804.92136
4cabozantinib4.3980
5foretinib4.3476
6tozasertib4.3375
7vandetanib4.3073
8ponatinib4.2670
9nilotinib4.1764
10bosutinib4.0858
11doramapimod4.0657
12quizartinib3.9953
13midostaurin3.8546
14pazopanib3.6939
15vatalanib3.6939
16sb 2021903.6437
17nintedanib3.6136
18regorafenib3.5634
19canertinib3.5333
20tae 6843.4330
21fedratinib3.4029
22bms 7776073.3728
23linifanib3.3327
24mln 80543.3327
25saracatinib3.3327
26neflamapimod3.3026
27tandutinib3.2224
28dovitinib3.0921
29dasatinib anhydrous3.0921
30lestaurtinib3.0420
31pacritinib3.0420
32lenvatinib3.0420
33danusertib2.9418
34defosbarasertib2.8917
35r 4062.8316
36cediranib2.8316
37milciclib2.7715
38masitinib2.7715
39pha 6657522.7114
40plx 47202.7114
41enmd 20762.7114
42kw 24492.6413
43tivozanib2.6413
44bemcentinib2.6413
45ast 4872.5612
46raf 2652.4811
47motesanib2.4811
48brivanib2.4811
49mk 51082.4811
50merestinib2.4811

Showing top 50 of 68 compounds. Use the BiohacksAI search to explore all DDR1 modulators.

About DDR1 as a Drug Target

DDR1 (discoidin domain receptor tyrosine kinase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 68 compounds with documented DDR1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

DDR1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.